Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Kairuļojošā zarnu slimību anketēšana× | Hroniskas sirds mazspējas aptauja× | |
|---|---|---|
| Nozare | Veselības iznākumi | Veselības iznākumi |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1994 | 2000 |
| Autors≠ | Elena J. Irvine et al. | Luc Guyonnet et al. |
| Tips | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| Pirmavots≠ | Guyonnet, S., Dupont, C., Mouterde, O., Chouraqui, J. P., Darmaun, D., & Goulet, O. (2001). Placebo-controlled trial of saccharomyces boulardii in gastroenteritis. Pediatrics, 107(2), E27. link ↗ | Guyonnet, S., Vellas, B., Garry, P. J., & Albarede, J. L. (2000). The Chronic Heart Failure Questionnaire: A pilot study of validity, reliability, and responsiveness. Journal of Cardiac Failure, 6(1), 21-26. link ↗ |
| Citi nosaukumi | IBDQ, IBD Questionnaire, Inflammatory Bowel Disease QoL | CHQ, Heart Failure Quality of Life, Chronic Heart Failure QoL |
| Saistītās | 4 | 4 |
| Kopsavilkums≠ | The IBDQ is a disease-specific quality of life measure for inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Developed by Elena Irvine and colleagues in 1994, this 32-item questionnaire measures how IBD affects bowel function, systemic symptoms, emotional well-being, and social functioning. It is the most widely used quality-of-life instrument in IBD research and clinical practice. | The CHQ is a disease-specific quality of life measure for chronic heart failure (CHF). Developed by Luc Guyonnet and colleagues in 2000, this 20-item questionnaire assesses how heart failure affects dyspnea, fatigue, emotional function, and activity limitation. It is used in heart failure clinical trials and research to quantify patient-experienced burden and treatment benefit. |
| ScholarGateDatu kopa ↗ |
|
|